SARS-CoV-2 Antigen Rapid Test

Providing an aid in early diagnosis of individuals who are suspected of COVID-19 by their healthcare provider and who are asymptomatic.

To contact us please click here!
Location:Home > ABOUT US > News > Launch Notification of FIA products
Launch Notification of FIA products
Date:2021-01-14 Click:

We are pleased to announce that the FIAflex Fluorescent Immunoassay Systemproduct series was officially launched! The seriesincludes FIAflex Fluorescent Immunoassay Analyzer, FIAflex SARS-CoV-2 Antigen FIA, and FIAflex Influenza A/B FIA.

FIAflex Fluorescent Immunoassay Analyzer is our latest fluorescent immunoassay device thatprovides excellent performance and improved user experience.The features of the device include:

- User-friendly interface

- Excellent sensitivity and specificity

- Small instrument size and room temperature storage

- QR code scanner

- Dual testing options

FIAflex SARS-CoV-2 Antigen FIA is a fluorescence lateral flow immunoassay that isused with the FIA analyzer for the qualitative detection of the nucleocapsidprotein antigen from SARS-CoV-2 in nasal swab specimens directly fromindividuals who are suspected of COVID-19 by their healthcare provider withinthe first 12 days of the onset of symptoms.


- Results in 15 minutes

- Room temperature storage

- CE marked

FIAflex Influenza A/B FIA is a fluorescencelateral flow immunoassay that is used with the FIA analyzer for thequalitative detection of Influenza virus type A and type B nucleoproteinantigens in nasal swab, nasopharyngeal swab or throat swab specimensdirectly from individuals who are suspected of influenza by their healthcareprovider.


- Accepts nasal swabs, nasopharyngealswabs, and throat swabs

- Room temperature storage

- 24-month shelf life from date ofmanufacture